Article
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.
Clinical pharmacology and therapeutics - 1 Nov 2019
Nicoletti Paola, Barrett Sarah, McEvoy Laurence, Daly Ann K, Aithal Guruprasad, Lucena M Isabel, Andrade Raul J, Wadelius Mia, Hallberg Pär, Stephens Camilla, Bjornsson Einar S, Friedmann Peter, Kainu Kati, Laitinen Tarja, Marson Anthony, Molokhia Mariam, Phillips Elizabeth, Pichler Werner, Romano Antonino, Shear Neil, Sills Graeme, Tanno Luciana K, Swale Ashley, Floratos Aris, Shen Yufeng, Nelson Matthew R, Watkins Paul B, Daly Mark J, Morris Andrew P, Alfirevic Ana, Pirmohamed Munir
Abstract excerpt
Carbamazepine (CBZ) causes life-threating T-cell-mediated hypersensitivity reactions, including serious cutaneous adverse reactions (SCARs) and drug-induced liver injury (CBZ-DILI). In order to evaluate shared or phenotype-specific genetic predisposing factors for CBZ hypersensitivity reactions, we performed a meta-analysis of two genomewide association studies (GWAS) on a total of 43 well-phenotyped Northern and...
Read the complete abstract on PubMedTopics
- Adult
- Anaplastic Lymphoma Kinase
- Carbamazepine
